Sibutramine-induced acute myocardial infarction in a young lady

Clinical Toxicology

Volumn 46, Issue 9, 2008, Pages 877-879

  Yim, Kin Ming Anfernee ^a,c   Ng, Hon Wah ^a   Chan, Chi Kin ^a   Yip, Gabriel ^b   Lau, Fei Lung ^a  

^a HOSPITAL AUTHORITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Acute myocardial infarction; Coronary spasm; Sibutramine

Indexed keywords

ACETYLSALICYLIC ACID; DILTIAZEM; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; SIBUTRAMINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY SPASM; DRUG URINE LEVEL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HUMAN; PHYSICAL EXAMINATION; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; URINALYSIS;

ADULT; APPETITE DEPRESSANTS; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; CYCLOBUTANES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; MYOCARDIAL INFARCTION; TROPONIN T;

EID: 55949121059     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650802136258     Document Type: Article

References (10)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Therap 1981; 30(2):239-245.
2. Lean MEJ. Sibutramine: a review of clinical efficacy. Int J Obes Relat Metab Disord 1997; 21:30-36.
3. Leo PJ, Hollander JE, Shih RD. Phenylpropanolamine and associated myocardial injury. Ann Emerg Med 1996; 28:359-362.
4. American Heart Association: Medical Treatment of Obesity. http:// www.americanheart.org/presenter.jhtml?identifier=1818. Accessed 9 December 2007.
5. Flomenbaum, NE, Goldfrank, LR, Hoffman, RS, Howland, MA, Lewin, NA, Nelson, LS (eds). Dieting agents and regimens. In: Toxicologic Emergencies. 8th ed. New York, USA: McGraw-Hill Professional; 2006: 623-624.
6. Health Research Group: Protecting Health, Safety and Democracy. http://www.citizen.org/publications/release.cfm?id=7160. Accessed 29 October 2007.
7. Wooltorton E. Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias. CMAJ 2002; 166(10):1307-1308.
8. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 2006;29(4):277-302.
9. Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res 1996; 4:263-270.
10. Azarisman SM, Magdi YA, Noorfaizan S, Oteh M. Myocardial infarction induced by appetite suppressants in Malaysia. NEJM 2007; 357(18):1873-1874.